-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Reiterates Outperform on Fulgent Genetics, Raises Price Target to $25

Benzinga·05/05/2025 13:48:53
Listen to the news
Raymond James analyst Andrew Cooper reiterates Fulgent Genetics (NASDAQ:FLGT) with a Outperform and raises the price target from $24 to $25.